Eli Lilly: Endowment proposes $347M share sale

Lilly Endowment, Inc. also reported four common-stock sales during the preceding three months, including 302,403 shares on August 19, 2026.

Rhea-AI Filing Summary

Eli Lilly and Company (LLY) is the issuer in a notice stating that shareholder Lilly Endowment, Inc. proposes to sell 300,000 common shares through J.P. Morgan Securities LLC. The reported aggregate market value is $347,247,000, with an approximate sale date of October 7, 2026; 941,357,065 shares are listed as outstanding. The notice is signed by Peter A. Buck, Vice President for Investments and Grants Administration.

Key Figures

Proposed shares for sale: 300,000 shares Aggregate market value: $347,247,000 Shares outstanding: 941,357,065 shares +2 more

5 metrics

Proposed shares for sale 300,000 shares Lilly Endowment, Inc.'s proposed sale

Aggregate market value $347,247,000 Proposed sale

Shares outstanding 941,357,065 shares Eli Lilly and Company

Shares sold 302,403 shares Lilly Endowment sale on August 19, 2026

Gross proceeds $385,708,676.04 Lilly Endowment sale on August 19, 2026

Key Terms

Rule 144, aggregated, securities to be sold

3 terms

Rule 144 regulatory

"paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

aggregated regulatory

"sales are required by paragraph (e) of Rule 144 to be aggregated"

securities to be sold financial

"144: Securities To Be Sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many LLY shares does Lilly Endowment propose to sell?

Lilly Endowment, Inc. proposes to sell 300,000 shares of Eli Lilly and Company common stock, with an aggregate market value of $347,247,000 and an approximate sale date of October 7, 2026.

How were Lilly Endowment's LLY shares acquired?

The common stock intended for sale is listed as a gift from J.K. Lilly Sr. Trust on February 10, 1948.

What LLY shares did Lilly Endowment sell in the prior three months?

Lilly Endowment reported sales of 80 shares with gross proceeds of $99,200 on July 7, 2026; 7,395 shares with gross proceeds of $9,172,695.88 on July 8, 2026; 122 shares with gross proceeds of $151,280 on August 13, 2026; and 302,403 shares with gross proceeds of $385,708,676.04 on August 19, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/07/2026 - 03:24 PM Accepted by SEC EDGAR 10/07/2026 - 03:24 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0000316011
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ELI LILLY AND COMPANY
SEC File Number	001-06351
Address of Issuer	LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS INDIANA 46285
Phone	317-276-2000
Name of Person for Whose Account the Securities are To Be Sold	LILLY ENDOWMENT, INC.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Shareholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 383 Madison Avenue New York NY 10179	300000	347247000	941357065	10/07/2026	NYSE, NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/10/1948	Gift	J.K. Lilly Sr. Trust		01/21/1937	38400000		N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	07/07/2026	80	99200
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	07/08/2026	7395	9172695.88
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	08/13/2026	122	151280
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	08/19/2026	302403	385708676.04

144: Remarks and Signature

Remarks
Date of Notice	10/07/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Peter A. Buck, Vice President for Investments and Grants Administration
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)